homocysteine has been researched along with Huntington Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Boll, C; Cárdenas, G; González-Guevara, E; Martínez-Lazcano, JC | 1 |
| Ferrante, RJ; Kubilis, J; Lee, J; Neve, R; Ratan, RR; Ross, BD; Ryu, H; Zaman, K | 1 |
| Agelink, MW; Andrich, J; Arz, A; Kraus, PH; Kuhn, W; Müller, T; Saft, C; Schneider, B | 1 |
| Defazio, G; Lamberti, P; Livrea, P; Martino, D; Zoccolella, S | 1 |
| Gray, PN; May, PC | 2 |
2 review(s) available for homocysteine and Huntington Disease
| Article | Year |
|---|---|
Gut dysbiosis and homocysteine: a couple for boosting neurotoxicity in Huntington disease.
Topics: Animals; Cytokines; Dysbiosis; Homocysteine; Humans; Huntington Disease; Lipopolysaccharides; Mice; Nerve Growth Factors | 2022 |
Hyperhomocysteinemia in movement disorders: Current evidence and hypotheses.
Topics: Adolescent; Adult; Animals; Case-Control Studies; Catechol O-Methyltransferase; Cystathionine beta-Synthase; Dopamine Agents; Dystonia; Homocysteine; Humans; Huntington Disease; Hyperhomocysteinemia; Levodopa; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Movement Disorders; Parkinson Disease; Prospective Studies | 2006 |
4 other study(ies) available for homocysteine and Huntington Disease
| Article | Year |
|---|---|
Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neurons.
Topics: Animals; Apoptosis; Cell Nucleus; Cell Survival; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; DNA; DNA Damage; DNA-Binding Proteins; Glutathione; Homocysteine; Huntington Disease; Male; Mice; Mice, Transgenic; Neurons; Nitro Compounds; Oxidants; Oxidative Stress; Propionates; Rats; Rats, Sprague-Dawley; Response Elements; Sp1 Transcription Factor; Sp3 Transcription Factor; Transcription Factors; Transfection; Zinc Fingers | 2003 |
Hyperhomocysteinaemia in treated patients with Huntington's disease homocysteine in HD.
Topics: Adult; Biomarkers; Central Nervous System Agents; Disease Progression; Drug Interactions; Female; Homocysteine; Humans; Huntingtin Protein; Huntington Disease; Hyperhomocysteinemia; Male; Metabolic Clearance Rate; Middle Aged; Mutation; Nerve Tissue Proteins; Neurologic Examination; Nuclear Proteins | 2004 |
The mechanism of glutamate-induced degeneration of cultured Huntington's disease and control fibroblasts.
Topics: Cells, Cultured; Cystine; Fibroblasts; Glutamates; Glutamic Acid; Glutathione; Homocysteine; Humans; Huntington Disease | 1985 |
L-Homocysteic acid as an alternative cytotoxin for studying glutamate-induced cellular degeneration of Huntington's disease and normal skin fibroblasts.
Topics: Aspartic Acid; Cell Survival; Cells, Cultured; Cysteic Acid; Cysteine; Fibroblasts; Glutamates; Glutamic Acid; Homocysteine; Humans; Huntington Disease; In Vitro Techniques; Isomerism; Kainic Acid; Kinetics; N-Methylaspartate; Neurotransmitter Agents; Skin; Time Factors | 1985 |